Abstract:AIM: To study the relationship between hepatitis B virus (HBV) DNA levels and liver histology in patients with chronic hepatitis B (CHB) and to determine the prevalence and characteristics of hepatitis B e antigen (HBeAg) negative patients.METHODS: A total of 213 patients with CHB were studied, and serum HBV DNA levels were measured by the COBAS Amplicor HBV Monitor test. All patients were divided into two groups according to the HBeAg status. The correlation between serum HBV DNA levels and liver damage (liver histology and biochemistry) was explored.RESULTS: Of the 213 patients with serum HBV DNA levels higher than 10(5) copies/mL, 178 (83.6%) were HBeAg positive, 35 (16.4%) were HBeAg negative. The serum HBV DNA levels were not correlated to the age, history of CHB, histological grade and stage of liver disease in either HBeAg negative or HBeAg positive patients. There was no correlation between serum levels of HBV DNA and alanine aminotransferanse (ALT), aspartate aminotrans-ferase (AST) in HBeAg positive patients. In HBeAg negative patients, there was no correlation between serum levels of HBV DNA and AST, while serum DNA levels correlated with ALT (r = 0.351, P = 0.042). The grade (G) of liver disease correlated with ALT and AST (P < 0.05, r = 0.205, 0.327 respectively) in HBeAg positive patients. In HBeAg negative patients, correlations were shown between ALT, AST and the G (P < 0.01, and r = 0.862, 0.802 respectively). HBeAg negative patients were older (35 9 years vs 30 9 years, P < 0.05) and had a longer history of HBV infection (8 4 years vs 6 4 years, P < 0.05) and a lower HBV DNA level than HBeAg positive patients (8.4 +/- 1.7 Log HBV DNA vs 9.8 +/- 1.3 Log HBV DNA, P < 0.001). There were no significant differences in sex ratio, ALT and AST levels and liver histology between the two groups.CONCLUSION: Serum HBV DNA level is not correlated to histological grade or stage of liver disease in CHB patients with HBV DNA more than 10(5) copies/mL. Compared to HBeAg positive patients, HBeAg negative patients are older and have a lower HBV DNA level and a longer HBV infection history. There is no significant difference in sex ratio, ALT and AST levels and liver histology between the two groups. (c) 2007 The WJG Press. All rights reserved.

Serum HBeAg and HBV DNA Levels Are Not Always Proportional and Only High Levels of HBeAg Most Likely Correlate with High Levels of HBV DNA: A Community-Based Study.

[Relationship between the quantitative results of HBV DNA and HBV markers (HBV M) in population with low-level HBsAg].

Epidemiological analysis of serum HBV DNA level among 13 039 patients with Hepatitis B

HBsAg Levels in HBeAg-positive Chronic Hepatitis B Patients with Different Immune Conditions.

The Measurement of HBV DNA in peripheral blood mononuclear cells and its clinical applicability

Serolological Profile among HBsAg-Positive Infections in Southeast China: A Community-Based Study

Quantitative HBsAg versus HBV DNA in Predicting Significant Hepatitis Activity of HBeAg-Positive Chronic HBV Infection

Hepatitis B surface antigen levels during natural history of chronic hepatitis B: a Chinese perspective study.

Quantitative Detection of HBsAg and HBeAg and Its Correlation with Serum HBV DNA Levels

Association Between Serum Levels Of Hepatitis B E-Antigen And Severity Of Liver Fibrosis

Relationship Between Hepatitis B Virus Dna Levels and Liver Histology in Patients with Chronic Hepatitis B

HBsAg as an important predictor of HBeAg seroconversion following antiviral treatment for HBeAg-positive chronic hepatitis B patients

Baseline Quantitative Hepatitis B Core Antibody Titre Alone Strongly Predicts HBeAg Seroconversion Across Chronic Hepatitis B Patients Treated with Peginterferon or Nucleos(t)ide Analogues.

Capabilities of Hepatitis B Surface Antigen Are Divergent from Hepatitis B Virus DNA in Delimiting Natural History Phases of Chronic Hepatitis B Virus Infection

Serum hepatitis B core-related antigen as a surrogate marker of hepatitis B e antigen seroconversion in chronic hepatitis B

A Predictive Value of Quantitative Hbsag for Serum Hbv Dna Level among Hbeag-Positive Pregnant Women

Prevalence and clinical characteristics of hepatitis B surface antigen-negative/hepatitis B core antibody-positive patients with detectable serum hepatitis B virus DNA

Quantitative Analyses of Intrahepatic HBV Cccdna and Serum HBsAg in 54 Patients with Chronic Hepatitis B

Mutations in hepatitis B virus DNA from patients with coexisting HBsAg and anti-HBs.

Correlation Between the Prevalence of Serum HBV DNA and Immunoserologic HBV Markers in the Subjects with or Without Hepatitis.

Quantitative Serum HBsAg and HBeAg Are Strong Predictors of Sustained HBeAg Seroconversion to Pegylated Interferon Alfa‐2b in HBeAg‐positive Patients